Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Status Disparities | 8 | 2023 | 642 | 1.530 |
Why?
|
| Environmental Exposure | 6 | 2020 | 216 | 1.320 |
Why?
|
| Public Health | 6 | 2023 | 372 | 1.260 |
Why?
|
| Education, Medical | 3 | 2023 | 104 | 1.200 |
Why?
|
| Students, Health Occupations | 1 | 2022 | 6 | 0.880 |
Why?
|
| Air Pollutants | 2 | 2020 | 94 | 0.800 |
Why?
|
| Vascular Diseases | 1 | 2020 | 30 | 0.730 |
Why?
|
| Poverty | 1 | 2023 | 348 | 0.720 |
Why?
|
| Particulate Matter | 1 | 2020 | 51 | 0.700 |
Why?
|
| Air Pollution | 1 | 2020 | 60 | 0.690 |
Why?
|
| Pregnancy Outcome | 2 | 2015 | 87 | 0.630 |
Why?
|
| Infant, Premature | 2 | 2015 | 129 | 0.630 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 126 | 0.630 |
Why?
|
| Humans | 38 | 2023 | 37093 | 0.630 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 125 | 0.630 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 664 | 0.600 |
Why?
|
| HIV Infections | 6 | 2022 | 2303 | 0.600 |
Why?
|
| Environmental Health | 2 | 2014 | 41 | 0.590 |
Why?
|
| Premature Birth | 2 | 2015 | 75 | 0.580 |
Why?
|
| Social Justice | 2 | 2011 | 55 | 0.570 |
Why?
|
| Models, Theoretical | 2 | 2014 | 217 | 0.540 |
Why?
|
| Infant, Low Birth Weight | 1 | 2015 | 39 | 0.530 |
Why?
|
| Infant Mortality | 1 | 2015 | 55 | 0.520 |
Why?
|
| Child Mortality | 1 | 2015 | 7 | 0.520 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2015 | 15 | 0.510 |
Why?
|
| Healthcare Disparities | 2 | 2015 | 494 | 0.470 |
Why?
|
| Databases, Factual | 1 | 2014 | 291 | 0.450 |
Why?
|
| Hospital Mortality | 1 | 2015 | 187 | 0.450 |
Why?
|
| Sequence Analysis | 1 | 2013 | 26 | 0.440 |
Why?
|
| United States | 14 | 2023 | 4223 | 0.440 |
Why?
|
| United States Public Health Service | 1 | 2012 | 8 | 0.440 |
Why?
|
| Human Experimentation | 1 | 2012 | 11 | 0.440 |
Why?
|
| Genome | 1 | 2013 | 125 | 0.410 |
Why?
|
| Homicide | 1 | 2012 | 15 | 0.410 |
Why?
|
| Firearms | 1 | 2012 | 16 | 0.410 |
Why?
|
| Human Genome Project | 1 | 2011 | 7 | 0.390 |
Why?
|
| Health Services Accessibility | 3 | 2023 | 560 | 0.380 |
Why?
|
| Adolescent | 8 | 2022 | 5363 | 0.370 |
Why?
|
| Infant, Newborn | 5 | 2019 | 894 | 0.360 |
Why?
|
| Physicians | 2 | 2023 | 163 | 0.360 |
Why?
|
| Genome, Human | 1 | 2011 | 135 | 0.360 |
Why?
|
| Cultural Competency | 1 | 2011 | 131 | 0.350 |
Why?
|
| Social Class | 1 | 2011 | 247 | 0.330 |
Why?
|
| Minority Groups | 2 | 2020 | 596 | 0.320 |
Why?
|
| Residence Characteristics | 3 | 2023 | 322 | 0.320 |
Why?
|
| Students, Medical | 2 | 2021 | 130 | 0.320 |
Why?
|
| Tennessee | 4 | 2022 | 70 | 0.310 |
Why?
|
| Young Adult | 6 | 2022 | 4268 | 0.300 |
Why?
|
| Risk Factors | 5 | 2023 | 3562 | 0.290 |
Why?
|
| Female | 15 | 2023 | 20969 | 0.280 |
Why?
|
| Anti-HIV Agents | 2 | 2021 | 420 | 0.280 |
Why?
|
| Automobile Driving | 1 | 2006 | 24 | 0.270 |
Why?
|
| Accidents, Traffic | 1 | 2006 | 42 | 0.270 |
Why?
|
| Primary Health Care | 3 | 2023 | 294 | 0.270 |
Why?
|
| Education, Medical, Graduate | 2 | 2023 | 55 | 0.270 |
Why?
|
| Socioeconomic Factors | 4 | 2019 | 1067 | 0.260 |
Why?
|
| Prejudice | 2 | 2019 | 110 | 0.250 |
Why?
|
| Alabama | 2 | 2015 | 51 | 0.240 |
Why?
|
| Pregnancy | 4 | 2022 | 1549 | 0.240 |
Why?
|
| Genital Neoplasms, Female | 1 | 2023 | 11 | 0.230 |
Why?
|
| Logistic Models | 3 | 2015 | 923 | 0.220 |
Why?
|
| Male | 9 | 2023 | 20025 | 0.220 |
Why?
|
| Microcephaly | 1 | 2022 | 19 | 0.210 |
Why?
|
| Cohort Studies | 3 | 2023 | 1492 | 0.210 |
Why?
|
| Melanoma | 1 | 2023 | 96 | 0.210 |
Why?
|
| Infant | 2 | 2015 | 1046 | 0.200 |
Why?
|
| Medicare | 4 | 2020 | 195 | 0.200 |
Why?
|
| Adult | 8 | 2022 | 11712 | 0.200 |
Why?
|
| Geographic Information Systems | 1 | 2002 | 39 | 0.200 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 159 | 0.200 |
Why?
|
| Educational Status | 1 | 2023 | 313 | 0.200 |
Why?
|
| Antihypertensive Agents | 2 | 2021 | 284 | 0.190 |
Why?
|
| Medically Underserved Area | 1 | 2002 | 104 | 0.190 |
Why?
|
| Population Groups | 1 | 2020 | 56 | 0.180 |
Why?
|
| Heart Diseases | 1 | 2021 | 104 | 0.180 |
Why?
|
| Mortality | 2 | 2013 | 145 | 0.180 |
Why?
|
| Schools, Medical | 3 | 2023 | 198 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 70 | 0.180 |
Why?
|
| Community Health Centers | 1 | 2020 | 45 | 0.180 |
Why?
|
| Homosexuality, Male | 2 | 2022 | 458 | 0.180 |
Why?
|
| Students, Dental | 1 | 2019 | 4 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 215 | 0.180 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 94 | 0.170 |
Why?
|
| Students, Nursing | 1 | 2019 | 39 | 0.160 |
Why?
|
| Social Environment | 1 | 2020 | 207 | 0.160 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 128 | 0.160 |
Why?
|
| Rural Population | 1 | 2020 | 294 | 0.160 |
Why?
|
| Stroke | 1 | 2021 | 286 | 0.160 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 66 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 198 | 0.150 |
Why?
|
| Health Policy | 2 | 2011 | 165 | 0.150 |
Why?
|
| Biomedical Research | 2 | 2013 | 400 | 0.150 |
Why?
|
| Nystatin | 1 | 2016 | 6 | 0.140 |
Why?
|
| beta-Cyclodextrins | 1 | 2016 | 24 | 0.140 |
Why?
|
| Middle Aged | 5 | 2020 | 10129 | 0.140 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 47 | 0.130 |
Why?
|
| Morbidity | 1 | 2015 | 91 | 0.130 |
Why?
|
| Pregnant Women | 1 | 2015 | 48 | 0.130 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 20 | 0.130 |
Why?
|
| Organizational Innovation | 1 | 2015 | 20 | 0.130 |
Why?
|
| Public Health Administration | 1 | 2014 | 26 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2023 | 2026 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 36 | 0.120 |
Why?
|
| Benzo(a)pyrene | 1 | 2016 | 126 | 0.120 |
Why?
|
| Mammography | 2 | 2012 | 188 | 0.120 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 1502 | 0.110 |
Why?
|
| Women | 1 | 2013 | 27 | 0.110 |
Why?
|
| Hypertension | 1 | 2020 | 796 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2014 | 238 | 0.110 |
Why?
|
| Information Systems | 1 | 2013 | 15 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2019 | 583 | 0.110 |
Why?
|
| Food Preferences | 1 | 2013 | 73 | 0.110 |
Why?
|
| Contact Tracing | 1 | 2012 | 19 | 0.110 |
Why?
|
| Urban Health | 1 | 2013 | 95 | 0.110 |
Why?
|
| Research Design | 1 | 2014 | 313 | 0.110 |
Why?
|
| Syphilis | 1 | 2012 | 23 | 0.110 |
Why?
|
| Minority Health | 1 | 2013 | 88 | 0.100 |
Why?
|
| Vegetables | 1 | 2013 | 147 | 0.100 |
Why?
|
| Macrophages | 1 | 2016 | 439 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 885 | 0.100 |
Why?
|
| Algorithms | 1 | 2014 | 465 | 0.100 |
Why?
|
| Prevalence | 1 | 2015 | 1455 | 0.100 |
Why?
|
| Child, Preschool | 1 | 2015 | 1418 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 358 | 0.090 |
Why?
|
| Bayes Theorem | 2 | 2021 | 94 | 0.090 |
Why?
|
| Culture | 1 | 2011 | 173 | 0.090 |
Why?
|
| Cultural Diversity | 1 | 2011 | 169 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 2721 | 0.080 |
Why?
|
| Health Behavior | 1 | 2013 | 537 | 0.080 |
Why?
|
| Aged | 3 | 2020 | 6741 | 0.080 |
Why?
|
| Child | 1 | 2015 | 3131 | 0.070 |
Why?
|
| Accident Prevention | 1 | 2006 | 7 | 0.070 |
Why?
|
| Seat Belts | 1 | 2006 | 5 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 2379 | 0.070 |
Why?
|
| SEER Program | 1 | 2023 | 91 | 0.060 |
Why?
|
| Risk-Taking | 1 | 2006 | 451 | 0.050 |
Why?
|
| Brazil | 1 | 2022 | 64 | 0.050 |
Why?
|
| Professional Practice Location | 1 | 2002 | 15 | 0.050 |
Why?
|
| Skin | 1 | 2023 | 174 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2023 | 441 | 0.050 |
Why?
|
| Sleep | 1 | 2023 | 152 | 0.050 |
Why?
|
| Community Health Services | 1 | 2023 | 185 | 0.050 |
Why?
|
| Curriculum | 1 | 2023 | 265 | 0.050 |
Why?
|
| Health Promotion | 1 | 2006 | 653 | 0.040 |
Why?
|
| Bisexuality | 1 | 2023 | 208 | 0.040 |
Why?
|
| Incidence | 1 | 2022 | 922 | 0.040 |
Why?
|
| Ohio | 1 | 2019 | 14 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2020 | 179 | 0.040 |
Why?
|
| Phenotype | 1 | 2019 | 689 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2016 | 50 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 237 | 0.030 |
Why?
|
| Survival Rate | 1 | 2014 | 311 | 0.030 |
Why?
|
| Intention | 1 | 2013 | 94 | 0.030 |
Why?
|
| Georgia | 1 | 2013 | 174 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 455 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1518 | 0.030 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2010 | 18 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2010 | 26 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2013 | 446 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2013 | 325 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 935 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 221 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1033 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 898 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 1908 | 0.020 |
Why?
|